AstraZeneca COVID-19 vaccine: clinical information
AstraZeneca vaccine training
All practice staff who will be administering the vaccine, including the supervising general practitioner, must complete the COVID-19 vaccine training before commencing vaccinations.
AstraZeneca vaccine Safety data
Read AstraZeneca’s Safety Data Sheet for information on what to do in the event of COVID-19 vaccine accidents:
Actions to take if vaccine is inhaled
Actions to take in case of skin contact
Actions to take in case of eye contact
Actions to take if vaccine is swallowed
The Safety Data Sheet also provides information on containment and cleaning up of spillage, and environmental precautions to prevent accidental release.
AstraZeneca vaccine and clotting conditions
ATAGI continues to recommend vaccination for people with blood clotting conditions, both with AstraZeneca and Pfizer, and maintain the benefits far outweigh any risks. See ATAGI released a statement for health care providers on the suitability of COVID-19 vaccines for people with a history of clotting conditions.
ATAGI has recommended that people with a confirmed medical history of heparin induced thrombocytopenia and cerebral venous sinus thrombosis defer vaccination while evidence specific to them is considered.
COVID-19 vaccination should be strongly encouraged for people with immunocompromise, however for some patients the optimal timing of vaccination requires special consideration.
AstraZeneca vaccine excess doses
Excess doses are vials of COVID-19 vaccine which will expire before the next scheduled vaccination clinic or when patients are booked for COVID-19 vaccine. Where possible, practices should aim to minimise excess doses.
Ensure your practice is familiar with the policy details: AstraZeneca excess doses. This is for general practices, GP Respiratory Clinics and Aboriginal Community Controlled Health Services.
COVID-19 vaccine: operational information
What is CVAS?
The CVAS (COVID-19 Vaccine Administration System) is a digital ordering and inventory management system that vaccination providers can use to order COVID-19 vaccines and related products, as well as report delivery acceptance, stock on hand and wastage.
Vaccination providers who have been onboarded to the Australian COVID 19 Vaccine Roll out Program by the Department of Health are able to use the CVAS.
If you need to correct information that you have inputted into the CVAS and you have access to the CVAS, you can make amendments directly in the CVAS. If you need further assistance, you can contact the Vaccine Operations Centre.
Following on-boarding, the VOC (Vaccine Operations Centre) will be the central contact point in the Department of Health to assist practices with the management of the operations component of the national COVID-19 vaccine roll-out program. The VOC will:
manage vaccine allocation and ordering across vaccination sites
manage and coordinate safe delivery and storage of vaccines with DHL and Linfox
coordinate the response to incidents impacting the COVID-19 vaccine roll-out program.
If your practice is having any issues with delivery or cold chain breaches, please report these to CVAS and the VOC as soon as possible.
Find a COVID-19 vaccine clinic
The Vaccine Clinic Finder currently contains week 1, 2 and 3 practices which have successfully registered in the COVID-19 Vaccine Administration System (CVAS). This list will be updated over the coming days and weeks in line with new registrations and orders, and new sites coming on board.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
Immunisation weekly update – 8 February 2023 HPV vaccination now single dose on NIP Changes from 6 February 2023 to human papillomavirus vaccination (Gardasil®9) dose schedule under the National Immunisation Program: Routine schedule for people aged 12 to 13 years will change to a single dose (previously a 2 dose…
Sydney World Pride 2023 – General Practice Support CESPHN is a proud supporter of the Sydney WorldPride 2023 that is occurring from 17 February to 5 March 2023. To assist people to get the right care and avoid unnecessary presentations to emergency departments, we are encouraging general practices to review…
COVID-19 weekly update – 08 JANUARY 2023 ATAGI 2023 Booster Advice The Australian Technical Advisory Group on Immunisation (ATAGI) have updated their recommendations on the use of booster doses of COVID-19 vaccine in 2023. ATAGI recommends a 2023 COVID-19 vaccine booster dose for adults in the following groups, if their…
MEDIA RELEASE: Canterbury Head to Health service opens doors to offer free, immediate mental health support. Canterbury Head to Health opened its doors in late January, offering free and immediate support for anyone in Canterbury and the surrounding regions experiencing distress or mental health concerns.Trained professionals are providing short to…
CESPHN Vax at Home service The CESPHN Vax at Home Service is for those people who are housebound and not able to leave their house to receive a COVID-19 vaccination or booster. The service will accept referrals for people 16 years and over. Referrals will be accepted from GPs and…
IAR-DST Training resumes today The implementation of the Initial Assessment and Referral Decision Support Tool (IAR-DST) training is gaining momentum both within CESPHN and nationally. National GP training numbers are closing in on 300 and over 50 of these have been trained by CESPHN. This year we are excited to…